These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20966402)

  • 41. Biomarkers, C-reactive proteins and statins in acute coronary syndromes.
    Ray KK
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():31-3. PubMed ID: 18001319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four-year follow-up of the Choice of Health Options In prevention of Cardiovascular Events randomized controlled trial.
    Neubeck L; Freedman SB; Briffa T; Bauman A; Redfern J
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):278-86. PubMed ID: 20606594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome.
    Naegeli B; Radovanovic D; Rickli H; Erne P; Seifert B; Duvoisin N; Pedrazzini G; Urban P; Bertel O
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):297-304. PubMed ID: 21450676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
    Eggers KM; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Jantzen F; Peter T; Allhoff T; Siegbahn A; Venge P; Wollert KC; Wallentin L
    Circ Cardiovasc Genet; 2010 Feb; 3(1):88-96. PubMed ID: 20160200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation between thrombolysis in myocardial infarction risk score and one-year outcomes for patients presenting at the emergency department with potential acute coronary syndrome.
    Weisenthal BM; Chang AM; Walsh KM; Collin MJ; Shofer FS; Hollander JE
    Am J Cardiol; 2010 Feb; 105(4):441-4. PubMed ID: 20152236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
    Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins.
    Ravipati G; Aronow WS; Ahn C; Channamsetty V; Sekhri V
    Am J Cardiol; 2006 Nov; 98(9):1170-1. PubMed ID: 17056320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
    Norozi K; Buchhorn R; Yasin A; Geyer S; Binder L; Seabrook JA; Wessel A
    Am Heart J; 2011 Jul; 162(1):131-5. PubMed ID: 21742099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early treatment of statins after acute coronary syndrome?].
    Hamm CW
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1941. PubMed ID: 21948603
    [No Abstract]   [Full Text] [Related]  

  • 53. [Leukocyte count as a risk factor for coronary adverse events among patients admitted for an acute coronary syndrome].
    Cabrerizo García S JL; Zalba E B; Pérez C JI; Ruiz R F
    Rev Med Chil; 2010 Mar; 138(3):274-80. PubMed ID: 20556328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Correlation between serum growth differentiation factor-15 and TIMI risk scores in patients with unstable angina pectoris].
    Deng MY; Wu GP; Feng XX; Luo JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1277-8. PubMed ID: 21764714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction.
    Minamisawa M; Motoki H; Izawa A; Kashima Y; Hioki H; Abe N; Miura T; Ebisawa S; Miyashita Y; Koyama J; Ikeda U
    Int Heart J; 2016; 57(1):11-7. PubMed ID: 26742699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya Acute Myocardial Infarction Study.
    Matsudaira K; Maeda K; Okumura N; Yoshikawa D; Morita Y; Mitsuhashi H; Ishii H; Kondo T; Murohara T;
    Circ J; 2012; 76(6):1509-16. PubMed ID: 22452999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome.
    Huerre C; Guiot A; Maréchaux S; Auffray JL; Bauchart JJ; Montaigne D; Mouquet F; Lesenne M; Puisieux F; Goldstein P; Asseman P; Ennezat PV
    Arch Cardiovasc Dis; 2010 Jan; 103(1):19-25. PubMed ID: 20142116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. After acute coronary syndrome, diabetic patients with peripheral vascular disease remain at high risk of cardiovascular events despite secondary prevention measures.
    Lafitte M; Barandon L; Pucheu Y; Pillois X; Gin H; Bonnet J; Couffinhal T
    Arch Cardiovasc Dis; 2010 Feb; 103(2):97-105. PubMed ID: 20226429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis.
    Wang Y; Zhen C; Wang R; Wang G
    Am J Emerg Med; 2019 Jul; 37(7):1346-1352. PubMed ID: 31029521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary Syndrome.
    Greer CE; Chew-Harris J; Adamson PD; Pemberton CJ; Pickering JW; Pilbrow AP; Frampton CM; Troughton RW; Doughty RN; Richards AM
    J Appl Lab Med; 2024 Jul; 9(4):672-683. PubMed ID: 38635817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.